Losartan inhibits collagen I synthesis and improves the distribution and efficacy of nanotherapeutics in tumors

Nanocarriers as an emerging platform for cancer therapy

Peer, D., Karp, J. M., Hong, S., Farokhzad, O. C., Margalit, R., & Langer, R. (2007) · Nature Nanotechnology · doi:10.1038/nnano.2007.387 · Cited by 8,710 · see citing works

Recent advances with liposomes as pharmaceutical carriers

Torchilin, V. P. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1632 · Cited by 5,282 · see citing works

Nanoparticle therapeutics: an emerging treatment modality for cancer

Davis, M. E., Chen, Z., & Shin, D. M. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2614 · Cited by 4,233 · see citing works

Delivering nanomedicine to solid tumors

Jain, R. K., & Stylianopoulos, T. (2010) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2010.139 · Cited by 3,196 · see citing works

Inhibition of Hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer

Olive, K. P., Jacobetz, M. A., Davidson, C. J., Gopinathan, A., McIntyre, D., Honess, D., Madhu, B., Goldgraben, M. A., Caldwell, M. E., Allard, D., et al. (2009) · Science · doi:10.1126/science.1171362 · Cited by 3,170 · see citing works

Collagens—structure, function, and biosynthesis

Gelse, K. (2003) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2003.08.002 · Cited by 2,663 · see citing works

Losartan, an AT1 Antagonist, Prevents Aortic Aneurysm in a Mouse Model of Marfan Syndrome

Habashi, J. P., Judge, D. P., Holm, T. M., Cohn, R. D., Loeys, B. L., Cooper, T. K., Myers, L., Klein, E. C., Liu, G., Calvi, C., et al. (2006) · Science · doi:10.1126/science.1124287 · Cited by 1,794 · see citing works

Molecular mechanisms of drug resistance

Longley, D., & Johnston, P. (2005) · The Journal of Pathology · doi:10.1002/path.1706 · Cited by 1,686 · see citing works

Role of extracellular matrix assembly in interstitial transport in solid tumors.

Netti, P. A., Berk, D. A., Swartz, M. A., Grodzinsky, A. J., & Jain, R. K. (2000) · PubMed · Cited by 1,165 · see citing works

Angiotensin II Blockade and Aortic-Root Dilation in Marfan's Syndrome

Brooke, B. S., Habashi, J. P., Judge, D. P., Patel, N. D., Loeys, B., & Dietz, H. C. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0706585 · Cited by 840 · see citing works

Dynamic imaging of collagen and its modulation in tumors in vivo using second-harmonic generation

Brown, E. B., McKee, T. D., DiTomaso, E., Pluen, A., Seed, B., Boucher, Y., & Jain, R. K. (2003) · Nature Medicine · doi:10.1038/nm879 · Cited by 836 · see citing works

Angiotensin II type 1 receptor blockade attenuates TGF-β–induced failure of muscle regeneration in multiple myopathic states

Cohn, R. D., van Erp, C., Habashi, J. P., Soleimani, A. A., Klein, E. C., Lisi, M. T., Gamradt, M., Rhys, C. M. A., Holm, T. M., Loeys, B., et al. (2007) · Nature Medicine · doi:10.1038/nm1536 · Cited by 671 · see citing works

Phase II Clinical Trial of a Granulocyte-Macrophage Colony-Stimulating Factor–Encoding, Second-Generation Oncolytic Herpesvirus in Patients With Unresectable Metastatic Melanoma

Senzer, N. N., Kaufman, H. L., AMATRUDA, T. T., Nemunaitis, M., Reid, T. R., Daniels, G. A., Gonzalez, R. C., Glaspy, J. A., Whitman, E. D., Harrington, K. J., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.24.3675 · Cited by 617 · see citing works

Role of tumor–host interactions in interstitial diffusion of macromolecules: Cranial vs. subcutaneous tumors

Pluen, A., Boucher, Y., Ramanujan, S., McKee, T. D., Gohongi, T., di Tomaso, E., Brown, E. B., Izumi, Y., Campbell, R. B., Berk, D. A., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.081626898 · Cited by 604 · see citing works

A Phase I Study of OncoVEXGM-CSF, a Second-Generation Oncolytic Herpes Simplex Virus Expressing Granulocyte Macrophage Colony-Stimulating Factor

Hu, J. C. C., Coffin, R. S., Davis, C. J., Graham, N. J., Groves, N., GUEST, P. J., Harrington, K. J., James, N. D., Love, C., McNeish, I. A., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0759 · Cited by 571 · see citing works

Diffusion and Convection in Collagen Gels: Implications for Transport in the Tumor Interstitium

Ramanujan, S., Pluen, A., McKee, T. D., Brown, E. B., Boucher, Y., & Jain, R. K. (2002) · Biophysical Journal · doi:10.1016/s0006-3495(02)73933-7 · Cited by 554 · see citing works

Do inhibitors of angiotensin-I-converting enzyme protect against risk of cancer?

Lever, A. F., Hole, D. J., Gillis, C. R., McCallum, I. R., McInnes, G. T., MacKinnon, P. L., Meredith, P., Murray, L. S., Reid, J. L., & Robertson, J. W. K. (1998) · The Lancet · doi:10.1016/s0140-6736(98)03228-0 · Cited by 542 · see citing works

Transforming growth factor-β in cancer and metastasis

Jakowlew, S. B. (2006) · Cancer and Metastasis Reviews · doi:10.1007/s10555-006-9006-2 · Cited by 519 · see citing works

Phase II Trial of Intratumoral Administration of ONYX-015, a Replication-Selective Adenovirus, in Patients With Refractory Head and Neck Cancer

Nemunaitis, J. J., Khuri, F. R., Ganly, I., Arseneau, J. C., Posner, M. R., Vokes, E. E., Kuhn, J. A., McCarty, T. M., Landers, S., Blackburn, A., et al. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.2.289 · Cited by 470 · see citing works

Angiotensin receptors: a new role in cancer?

Deshayes, F., & Nahmias, C. (2005) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2005.07.009 · Cited by 437 · see citing works

Comparative effects of chronic angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade on cardiac remodeling after myocardial infarction in the rat.

Schieffer, B., Wirger, A., Meybrunn, M., Seitz, S., Holtz, J., Riede, U. N., & Drexler, H. (1994) · Circulation · doi:10.1161/01.cir.89.5.2273 · Cited by 420 · see citing works

Degradation of Fibrillar Collagen in a Human Melanoma Xenograft Improves the Efficacy of an Oncolytic Herpes Simplex Virus Vector

McKee, T. D., Grandi, P., Mok, W., Alexandrakis, G., Insin, N., Zimmer, J. P., Bawendi, M. G., Boucher, Y., Breakefield, X. O., & Jain, R. K. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2242 · Cited by 397 · see citing works

Angiotensin II Blockade Reverses Myocardial Fibrosis in a Transgenic Mouse Model of Human Hypertrophic Cardiomyopathy

Lim, D., Lutucuta, S., Bachireddy, P., Youker, K. A., Evans, A. J., Entman, M. L., Roberts, R., & Marian, A. J. (2001) · Circulation · doi:10.1161/01.cir.103.6.789 · Cited by 387 · see citing works

Angiotensin II Activates the Smad Pathway in Vascular Smooth Muscle Cells by a Transforming Growth Factor-β–Independent Mechanism

Rodríguez‐Vita, J., Sánchez‐López, E., Esteban, V., Rupérez, M., Egido, J., & Ruiz‐Ortega, M. (2005) · Circulation · doi:10.1161/01.cir.0000165133.84978.e2 · Cited by 326 · see citing works

The renin-angiotensin system and malignancy

Ager, E. I., Neo, J. H., & Christophi, C. (2008) · Carcinogenesis · doi:10.1093/carcin/bgn171 · Cited by 296 · see citing works

Renal injury due to renin–angiotensin–aldosterone system activation of the transforming growth factor-β pathway

Wolf, G. (2006) · Kidney International · doi:10.1038/sj.ki.5001846 · Cited by 292 · see citing works

Extravascular diffusion in normal and neoplastic tissues.

Nugent, L. J., & Jain, R. K. (1984) · PubMed · Cited by 290 · see citing works

Clinical Pharmacokinetics of Losartan

Sica, D. A., Gehr, T. W. B., & Ghosh, S. S. (2005) · Clinical Pharmacokinetics · doi:10.2165/00003088-200544080-00003 · Cited by 260 · see citing works

Angiotensin II Induces Connective Tissue Growth Factor and Collagen I Expression via Transforming Growth Factor–β–Dependent and –Independent Smad Pathways

Yang, F., Chung, A. C. K., Huang, X. R., & Lan, H. Y. (2009) · Hypertension · doi:10.1161/hypertensionaha.109.136531 · Cited by 258 · see citing works

Tumor Blood Flow-Characterization, Modifications, and Role in Hyperthermia

Jain, R. K., & Ward-Hartley, K. A. (1984) · IEEE Transactions on Sonics and Ultrasonics · doi:10.1109/t-su.1984.31536 · Cited by 225 · see citing works

Angiotensin receptor antagonists: focus on losartan

Johnston, C. I. (1995) · The Lancet · doi:10.1016/s0140-6736(95)92411-6 · Cited by 212 · see citing works

Relaxin Expression From Tumor-Targeting Adenoviruses and Its Intratumoral Spread, Apoptosis Induction, and Efficacy

Kim, J.-H., Lee, Y.-S., Kim, H., Huang, J.-H., Yoon, A. R., & Yun, C. (2006) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djj397 · Cited by 211 · see citing works

Regression of Renal Vascular and Glomerular Fibrosis

Boffa, J., Lu, Y., Placier, S., Stefański, A., Dussaule, J., & Chatziantoniou, C. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000060574.38107.3b · Cited by 188 · see citing works

AGTR1 overexpression defines a subset of breast cancer and confers sensitivity to losartan, an AGTR1 antagonist

Rhodes, D. R., Ateeq, B., Cao, Q., Tomlins, S. A., Mehra, R., Laxman, B., Sundaram, S. K., Lonigro, R. J., Helgeson, B. E., Bhojani, M. S., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0900351106 · Cited by 172 · see citing works

Angiotensin II type I antagonist prevents pulmonary metastasis of murine renal cancer by inhibiting tumor angiogenesis.

Miyajima, A., Kosaka, T., Asano, T., Asano, T., Seta, K., Kawai, T., & Hayakawa, M. (2002) · PubMed · Cited by 158 · see citing works

Angiotensin type 1a receptor signaling-dependent induction of vascular endothelial growth factor in stroma is relevant to tumor-associated angiogenesis and tumor growth

Fujita, M. (2004) · Carcinogenesis · doi:10.1093/carcin/bgh324 · Cited by 156 · see citing works

Matrix Metalloproteinases-1 and -8 Improve the Distribution and Efficacy of an Oncolytic Virus

Mok, W., Boucher, Y., & Jain, R. K. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-3107 · Cited by 153 · see citing works

Distribution of Extracellular Matrix Proteins in Pancreatic Ductal Adenocarcinoma and Its Influence on Tumor Cell Proliferation in Vitro

Mollenhauer, J. A., Roether, I., & Kern, H. F. (1987) · Pancreas · doi:10.1097/00006676-198701000-00003 · Cited by 145 · see citing works

Neutralization of transforming growth factor-β attenuates hypertension and prevents renal injury in uremic rats

Lavoie, P., Robitaille, G., Agharazii, M., Ledbetter, S., Lebel, M., & Larivière, R. (2005) · Journal of Hypertension · doi:10.1097/01.hjh.0000182521.44440.c5 · Cited by 141 · see citing works

Pancreatic Cancer: Pathobiology, Treatment Options, and Drug Delivery

Li, J., Wientjes, M. G., & Au, J. L. ‐. (2010) · The AAPS Journal · doi:10.1208/s12248-010-9181-5 · Cited by 120 · see citing works

TGF-β in the pathogenesis and prevention of disease: a matter of aneurysmic proportions

Dietz, H. C. (2010) · Journal of Clinical Investigation · doi:10.1172/jci42014 · Cited by 118 · see citing works

Antihypertensives as Novel Antineoplastics: Angiotensin-I-Converting Enzyme Inhibitors and Angiotensin II Type 1 Receptor Blockers in Pancreatic Ductal Adenocarcinoma

Arafat, H. A., Gong, Q., Chipitsyna, G. I., Rizvi, A., Saa, C. T., & Yeo, C. J. (2007) · Journal of the American College of Surgeons · doi:10.1016/j.jamcollsurg.2007.01.067 · Cited by 111 · see citing works

Relaxin-Expressing, Fiber Chimeric Oncolytic Adenovirus Prolongs Survival of Tumor-Bearing Mice

Ganesh, S., Edick, M. G., Idamakanti, N., Abramova, M., VanRoey, M. J., Robinson, M. J., Yun, C., & Jooss, K. U. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4260 · Cited by 96 · see citing works

Angiotensin-(1-7) Reduces Fibrosis in Orthotopic Breast Tumors

Cook, K. L., Metheny‐Barlow, L. J., Tallant, E. A., & Gallagher, P. E. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-1136 · Cited by 92 · see citing works

Angiotensin inhibition and malignancies: a review

Rosenthal, T., & Gavras, I. (2009) · Journal of Human Hypertension · doi:10.1038/jhh.2009.21 · Cited by 83 · see citing works

Angiotensin converting enzyme inhibitors for cancer treatment?

Nielsen, D. L., Jensen, B. V., Eriksen, J., Skovsgaard, T., & Lindberg, H. (2004) · Acta Oncologica · doi:10.1080/02841860310022346 · Cited by 77 · see citing works

Dexamethasone reduces the interstitial fluid pressure in a human colon adenocarcinoma xenograft.

Kristjansen, P. E. G., Boucher, Y., & Jain, R. K. (1993) · PubMed · Cited by 75 · see citing works

Inhibition of angiotensin II receptor 1 limits tumor-associated angiogenesis and attenuates growth of murine melanoma

Otake, A. H., Mattar, A. L., Freitas, H., Machado, C. M. L., Nonogaki, S., Fujihara, C. K., Zatz, R., & Chammas, R. J. (2009) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-009-1136-0 · Cited by 58 · see citing works

Effects of Angiotensin II Subtype 1 Receptor Blockade by Losartan on Tubulointerstitial Lesions Caused by Hyperoxaluria

Toblli, J. E., Ferder, L., Stella, I., de Cavanagh, E. M. V., Angerosa, M., & Inserra, F. (2002) · The Journal of Urology · doi:10.1016/s0022-5347(05)64519-3 · Cited by 58 · see citing works

Effect of angiotensin II induced hypertension on tumor blood flow and interstitial fluid pressure.

Zlotecki, R. A., Boucher, Y., Lee, I., Baxter, L. T., & Jain, R. K. (1993) · PubMed · Cited by 57 · see citing works

Synergistic inhibitory effect of gemcitabine and angiotensin type-1 receptor blocker, losartan, on murine pancreatic tumor growth via anti-angiogenic activities

Yoshiji, H. (2009) · Oncology Reports · doi:10.3892/or_00000445 · Cited by 48 · see citing works

Navigating the clinical development landscape for oncolytic viruses and other cancer therapeutics: No shortcuts on the road to approval

Breitbach, C. J., Reid, T. R., Burke, J., Bell, J. C., & Kirn, D. H. (2010) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2010.02.001 · Cited by 42 · see citing works

ANGIOTENSIN II TYPE 1 RECEPTOR ANTAGONIST (LOSARTAN) DOWN-REGULATES TRANSFORMING GROWTH FACTOR-β IN EXPERIMENTAL ACUTE PYELONEPHRITIS

Khalil, A., Tullus, K., Bakhiet, M., BURMAN, L. G., Jaremko, G., & Brauner, A. (2000) · The Journal of Urology · doi:10.1016/s0022-5347(05)67492-7 · Cited by 25 · see citing works

ACE inhibitor bulks up muscle

Chamberlain, J. S. (2007) · Nature Medicine · doi:10.1038/nm0207-125 · Cited by 25 · see citing works

Principles of nanoparticle design for overcoming biological barriers to drug delivery

Blanco, E., Shen, H., & Ferrari, M. (2015) · Nature Biotechnology · doi:10.1038/nbt.3330 · Cited by 7,002 · see citing works

Doxil® — The first FDA-approved nano-drug: Lessons learned

Barenholz, Y. (. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.03.020 · Cited by 4,792 · see citing works

A framework for advancing our understanding of cancer-associated fibroblasts

Sahai, E., Astsaturov, I., Cukierman, E., DeNardo, D. G., Egeblad, M., Evans, R. M., Fearon, D., Greten, F. R., Hingorani, S. R., Hunter, T., et al. (2020) · Nature Reviews Cancer · doi:10.1038/s41568-019-0238-1 · Cited by 3,863 · see citing works

Cancer nanotechnology: The impact of passive and active targeting in the era of modern cancer biology

Bertrand, N., Wu, J., Xu, X., Kamaly, N., & Farokhzad, O. C. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.11.009 · Cited by 2,865 · see citing works

Crosstalk between cancer‐associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives

Mao, X., Xu, J., Wang, W., Liang, C., Hua, J., Liu, J., Zhang, B., Meng, Q., Yu, X., & Shi, S. (2021) · Molecular Cancer · doi:10.1186/s12943-021-01428-1 · Cited by 2,290 · see citing works

Oncolytic virotherapy

Russell, S. J., Peng, K.-W., & Bell, J. C. (2012) · Nature Biotechnology · doi:10.1038/nbt.2287 · Cited by 1,428 · see citing works

IL1-Induced JAK/STAT Signaling Is Antagonized by TGFβ to Shape CAF Heterogeneity in Pancreatic Ductal Adenocarcinoma

Biffi, G., Oni, T. E., Spielman, B., Hao, Y., Elyada, E., Park, Y., Preall, J., & Tuveson, D. A. (2019) · Cancer Discovery · doi:10.1158/2159-8290.cd-18-0710 · Cited by 1,360 · see citing works

Diversity and biology of cancer-associated fibroblasts

Biffi, G., & Tuveson, D. A. (2021) · Physiological Reviews · doi:10.1152/physrev.00048.2019 · Cited by 1,265 · see citing works

The tumour microenvironment in pancreatic cancer — clinical challenges and opportunities

Ho, W. J., Jaffee, E. M., & Zheng, L. (2020) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-020-0363-5 · Cited by 1,295 · see citing works

Normalizing Tumor Microenvironment to Treat Cancer: Bench to Bedside to Biomarkers

Jain, R. K. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.46.3653 · Cited by 1,248 · see citing works

Tumor targeting via EPR: Strategies to enhance patient responses

Golombek, S. K., May, J.-N., Theek, B., Appold, L., Drude, N., Kiessling, F., & Lammers, T. (2018) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.07.007 · Cited by 1,262 · see citing works

Smart cancer nanomedicine

van der Meel, R., Sulheim, E., Shi, Y., Kiessling, F. M., Mulder, W. J. M., & Lammers, T. (2019) · Nature Nanotechnology · doi:10.1038/s41565-019-0567-y · Cited by 1,251 · see citing works

Challenges and strategies in anti-cancer nanomedicine development: An industry perspective

Hare, J. I., Lammers, T., Ashford, M. B., Puri, S., Storm, G., & Barry, S. T. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.04.025 · Cited by 1,246 · see citing works

Targeting Tumor Microenvironment for Cancer Therapy

Roma-Rodrigues, C., Mendes, R., Baptista, P. V., & Fernandes, A. R. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20040840 · Cited by 1,187 · see citing works

Extracellular Matrix in the Tumor Microenvironment and Its Impact on Cancer Therapy

Henke, E., Nandigama, R., & Ergün, S. (2020) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2019.00160 · Cited by 1,142 · see citing works

Nanodrug Delivery: Is the Enhanced Permeability and Retention Effect Sufficient for Curing Cancer?

Nakamura, Y., Mochida, A., Choyke, P. L., & Kobayashi, H. (2016) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.6b00437 · Cited by 1,107 · see citing works

Rethinking cancer nanotheranostics

Chen, H., Zhang, W., Zhu, G., Xie, J., & Chen, X. S. (2017) · Nature Reviews Materials · doi:10.1038/natrevmats.2017.24 · Cited by 1,107 · see citing works

The Role of Mechanical Forces in Tumor Growth and Therapy

Jain, R. K., Martin, J. D., & Stylianopoulos, T. (2014) · Annual Review of Biomedical Engineering · doi:10.1146/annurev-bioeng-071813-105259 · Cited by 1,044 · see citing works

Angiotensin inhibition enhances drug delivery and potentiates chemotherapy by decompressing tumour blood vessels

Chauhan, V. P., Martin, J. D., Liu, H., Lacorre, D. A., Jain, S. R., Kozin, S. V., Stylianopoulos, T., Mousa, A. S., Han, X., Adstamongkonkul, P., et al. (2013) · Nature Communications · doi:10.1038/ncomms3516 · Cited by 1,031 · see citing works

Extracellular matrix and its therapeutic potential for cancer treatment

Huang, J., Zhang, L., Wan, D., Zhou, L., Zheng, S., Lin, S., & Qiao, Y. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00544-0 · Cited by 962 · see citing works

Pancreatic cancer stroma: an update on therapeutic targeting strategies

Hosein, A. N., Brekken, R. A., & Maitra, A. (2020) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-020-0300-1 · Cited by 950 · see citing works

Causes, consequences, and remedies for growth-induced solid stress in murine and human tumors

Stylianopoulos, T., Martin, J. D., Chauhan, V. P., Jain, S. R., Diop-Frimpong, B., Bardeesy, N., Smith, B. L., Ferrone, C. R., Hornicek, F. J., Boucher, Y., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1213353109 · Cited by 943 · see citing works

Fibroblast heterogeneity in the cancer wound

Öhlund, D., Elyada, E., & Tuveson, D. A. (2014) · The Journal of Experimental Medicine · doi:10.1084/jem.20140692 · Cited by 940 · see citing works

The roles of TGFβ in the tumour microenvironment

Pickup, M. W., Novitskiy, S. V., & Moses, H. L. (2013) · Nature reviews. Cancer · doi:10.1038/nrc3603 · Cited by 914 · see citing works

Strategies for advancing cancer nanomedicine

Chauhan, V. P., & Jain, R. K. (2013) · Nature Materials · doi:10.1038/nmat3792 · Cited by 815 · see citing works

Transport of drugs from blood vessels to tumour tissue

Dewhirst, M. W., & Secomb, T. W. (2017) · Nature Reviews Cancer · doi:10.1038/nrc.2017.93 · Cited by 749 · see citing works

Conquering the Hypoxia Limitation for Photodynamic Therapy

Wan, Y., Fu, L., Li, C., Lin, J., & Huang, P. (2021) · Advanced Materials · doi:10.1002/adma.202103978 · Cited by 705 · see citing works

Improving cancer immunotherapy using nanomedicines: progress, opportunities and challenges

Martin, J. D., Cabral, H., Stylianopoulos, T., & Jain, R. K. (2020) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-019-0308-z · Cited by 688 · see citing works

Recent Advances in Tumor Targeting via EPR Effect for Cancer Treatment

Subhan, M. A., Yalamarty, S. S. K., Filipczak, N., Parveen, F., & Torchilin, V. P. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11060571 · Cited by 623 · see citing works

Ligand-Targeted Drug Delivery

Srinivasarao, M., & Low, P. S. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00013 · Cited by 615 · see citing works

Delivery of Molecular and Nanoscale Medicine to Tumors: Transport Barriers and Strategies

Chauhan, V. P., Stylianopoulos, T., Boucher, Y., & Jain, R. K. (2011) · Annual Review of Chemical and Biomolecular Engineering · doi:10.1146/annurev-chembioeng-061010-114300 · Cited by 597 · see citing works

Reengineering the Physical Microenvironment of Tumors to Improve Drug Delivery and Efficacy: From Mathematical Modeling to Bench to Bedside

Stylianopoulos, T., Munn, L. L., & Jain, R. K. (2018) · Trends in cancer · doi:10.1016/j.trecan.2018.02.005 · Cited by 571 · see citing works

The Extracellular Matrix Modulates the Metastatic Journey

Kai, F., Drain, A. P., & Weaver, V. M. (2019) · Developmental Cell · doi:10.1016/j.devcel.2019.03.026 · Cited by 535 · see citing works

Improving drug delivery to solid tumors: Priming the tumor microenvironment

Khawar, I. A., Kim, J. H., & Kuh, H.-J. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.12.018 · Cited by 533 · see citing works

Total Neoadjuvant Therapy With FOLFIRINOX in Combination With Losartan Followed by Chemoradiotherapy for Locally Advanced Pancreatic Cancer

Murphy, J. E., Wo, J. Y.-L., Ryan, D. P., Clark, J. W., Jiang, W., Yeap, B. Y., Drapek, L. C., Ly, L., Baglini, C. V., Blaszkowsky, L. S., et al. (2019) · JAMA Oncology · doi:10.1001/jamaoncol.2019.0892 · Cited by 525 · see citing works

Combining two strategies to improve perfusion and drug delivery in solid tumors

Stylianopoulos, T., & Jain, R. K. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1318415110 · Cited by 508 · see citing works

The Use of Alternative Strategies for Enhanced Nanoparticle Delivery to Solid Tumors

Izci, M., Maksoudian, C., Manshian, B. B., & Soenen, S. J. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.0c00779 · Cited by 506 · see citing works

Fibroblasts in cancer: Unity in heterogeneity

Chhabra, Y., & Weeraratna, A. T. (2023) · Cell · doi:10.1016/j.cell.2023.03.016 · Cited by 488 · see citing works

Fluorescent Nanorods and Nanospheres for Real‐Time In Vivo Probing of Nanoparticle Shape‐Dependent Tumor Penetration

Chauhan, V. P., Popović, Z., Chen, O., Cui, J., Fukumura, D., Bawendi, M. G., & Jain, R. K. (2011) · Angewandte Chemie International Edition · doi:10.1002/anie.201104449 · Cited by 474 · see citing works

Combining Nanomedicine and Immunotherapy

Shi, Y., & Lammers, T. (2019) · Accounts of Chemical Research · doi:10.1021/acs.accounts.9b00148 · Cited by 460 · see citing works

Obesity-induced inflammation and desmoplasia promote pancreatic cancer progression and resistance to chemotherapy

Incio, J., Liu, H., Suboj, P., Chin, S. M., Chen, I. X., Pinter, M., Ng, M., Nia, H., Grahovac, J., Kao, S., et al. (2016) · Cancer Discovery · doi:10.1158/2159-8290.cd-15-1177 · Cited by 397 · see citing works

The Role of Tumor Microenvironment in Cancer Metastasis: Molecular Mechanisms and Therapeutic Opportunities

Neophytou, C. M., Panagi, M., Stylianopoulos, T., & Papageorgis, P. (2021) · Cancers · doi:10.3390/cancers13092053 · Cited by 468 · see citing works

Stimuli-Responsive Nano-Architecture Drug-Delivery Systems to Solid Tumor Micromilieu: Past, Present, and Future Perspectives

El‐Sawy, H. S., Al-Abd, A. M., Ahmed, T. A., El‐Say, K. M., & Torchilin, V. P. (2018) · ACS Nano · doi:10.1021/acsnano.8b06104 · Cited by 435 · see citing works

Engineered nanomedicines with enhanced tumor penetration

Ding, J., Chen, J., Gao, L., Jiang, Z., Zhang, Y., Li, M., Xiao, Q., Lee, S. S., & Chen, X. (2019) · Nano Today · doi:10.1016/j.nantod.2019.100800 · Cited by 422 · see citing works

Fluids and their mechanics in tumour transit: shaping metastasis

Follain, G., Herrmann, D., Harlepp, S., Hyenne, V., Osmani, N., Warren, S. C., Timpson, P., & Goetz, J. G. (2019) · Nature reviews. Cancer · doi:10.1038/s41568-019-0221-x · Cited by 413 · see citing works

Alliance with EPR Effect: Combined Strategies to Improve the EPR Effect in the Tumor Microenvironment

Park, J., Choi, Y., Chang, H., Um, W., Ryu, J. H., & Kwon, I. C. (2019) · Theranostics · doi:10.7150/thno.37198 · Cited by 385 · see citing works

Nanocarrier-based drug combination therapy for glioblastoma

Zhao, M., van Straten, D., Broekman, M. L. D., Véronique Préat, A., & Schiffelers, R. M. (2020) · Theranostics · doi:10.7150/thno.38147 · Cited by 376 · see citing works

The Current Landscape of Immune Checkpoint Blockade in Hepatocellular Carcinoma

Pinter, M., Jain, R. K., & Duda, D. G. (2020) · JAMA Oncology · doi:10.1001/jamaoncol.2020.3381 · Cited by 344 · see citing works

Reversal of pancreatic desmoplasia by re-educating stellate cells with a tumour microenvironment-activated nanosystem

Han, X., Li, Y., Xu, Y., Zhao, X., Zhang, Y., Yang, X., Wang, Y., Zhao, R., Anderson, G. J., Zhao, Y., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-05906-x · Cited by 339 · see citing works

Targeting the renin-angiotensin system to improve cancer treatment: Implications for immunotherapy

Pinter, M., & Jain, R. K. (2017) · Science Translational Medicine · doi:10.1126/scitranslmed.aan5616 · Cited by 335 · see citing works

Microenvironmental Determinants of Pancreatic Cancer

Heßmann, E., Buchholz, S., Demir, İ. E., Singh, S. K., Gress, T. M., Ellenrieder, V., & Neeße, A. (2020) · Physiological Reviews · doi:10.1152/physrev.00042.2019 · Cited by 328 · see citing works

TGF-β blockade improves the distribution and efficacy of therapeutics in breast carcinoma by normalizing the tumor stroma

Liu, J., Liao, S., Diop-Frimpong, B., Chen, W., Goel, S., Naxerova, K., Ancukiewicz, M., Boucher, Y., Jain, R. K., & Xu, L. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1117610109 · Cited by 332 · see citing works

Nanomedicine for tumor microenvironment modulation and cancer treatment enhancement

Liu, J., Chen, Q., Feng, L., & Liu, Z. (2018) · Nano Today · doi:10.1016/j.nantod.2018.06.008 · Cited by 329 · see citing works

Tumor microenvironment signaling and therapeutics in cancer progression

Goenka, A., Khan, F., Verma, B., Sinha, P., Dmello, C. C., Jogalekar, M. P., Gangadaran, P., & Ahn, B. (2023) · Cancer Communications · doi:10.1002/cac2.12416 · Cited by 323 · see citing works

CAF Subpopulations: A New Reservoir of Stromal Targets in Pancreatic Cancer

Pereira, B., Vennin, C., Papanicolaou, M., Chambers, C. R., Herrmann, D., Morton, J. P., Cox, T. R., & Timpson, P. (2019) · Trends in cancer · doi:10.1016/j.trecan.2019.09.010 · Cited by 309 · see citing works

Doxorubicin and other anthracyclines in cancers: Activity, chemoresistance and its overcoming

Mattioli, R., Ilari, A., Colotti, B., Mosca, L., Fazi, F., & Colotti, G. (2023) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2023.101205 · Cited by 303 · see citing works

Nanomedicine Tumor Targeting

Lammers, T. (2024) · Advanced Materials · doi:10.1002/adma.202312169 · Cited by 295 · see citing works

Hyaluronidase Embedded in Nanocarrier PEG Shell for Enhanced Tumor Penetration and Highly Efficient Antitumor Efficacy

Zhou, H., Fan, Z., Deng, J., Lemons, P. K., Arhontoulis, D. C., Bowne, W. B., & Cheng, H. (2016) · Nano Letters · doi:10.1021/acs.nanolett.6b00820 · Cited by 294 · see citing works

Quercetin Remodels the Tumor Microenvironment To Improve the Permeation, Retention, and Antitumor Effects of Nanoparticles

Hu, K., Miao, L., Goodwin, T. J., Li, J., Liu, Q., & Huang, L. (2017) · ACS Nano · doi:10.1021/acsnano.7b01522 · Cited by 293 · see citing works

Matrix metalloproteinase-sensitive size-shrinkable nanoparticles for deep tumor penetration and pH triggered doxorubicin release

Ruan, S., Cao, X., Cun, X., Hu, G., Zhou, Y., Zhang, Y., Lu, L., He, Q., & Gao, H. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2015.05.006 · Cited by 291 · see citing works

Pulmonary delivery of nanoparticle chemotherapy for the treatment of lung cancers: challenges and opportunities

Mangal, S., Gao, W., Li, T., & Zhou, Q. T. (2017) · Acta Pharmacologica Sinica · doi:10.1038/aps.2017.34 · Cited by 290 · see citing works

Design considerations for nanotherapeutics in oncology

Stylianopoulos, T., & Jain, R. K. (2015) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2015.07.015 · Cited by 284 · see citing works

Influencing factors and strategies of enhancing nanoparticles into tumors in vivo

Zhang, M., Gao, S., Yang, D., Fang, Y., Lin, X., Jin, X., Liu, Y., Liu, X., Su, K., & Shi, K. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.03.033 · Cited by 277 · see citing works

Engineering cell alignment in vitro

Li, Y., Huang, G., Zhang, X., Wang, L., Du, Y., Lu, T. J., & Xu, F. (2013) · Biotechnology Advances · doi:10.1016/j.biotechadv.2013.11.007 · Cited by 273 · see citing works

Mitochondria as a therapeutic target for ischemic stroke

He, Z., Ning, N., Zhou, Q., Khoshnam, S. E., & Farzaneh, M. (2019) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2019.11.005 · Cited by 269 · see citing works

Stromal barriers and strategies for the delivery of nanomedicine to desmoplastic tumors

Miao, L., Lin, C. M., & Huang, L. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.08.017 · Cited by 264 · see citing works

Losartan treatment enhances chemotherapy efficacy and reduces ascites in ovarian cancer models by normalizing the tumor stroma

Zhao, Y., Cao, J., Melamed, A., Worley, M. J., Gockley, A. A., Jones, D., Nia, H. T., Zhang, Y., Stylianopoulos, T., Kumar, A. S., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1818357116 · Cited by 262 · see citing works

Unlocking the Power of Exosomes for Crossing Biological Barriers in Drug Delivery

Elliott, R. O., & He, M. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13010122 · Cited by 263 · see citing works

Reversing insufficient photothermal therapy-induced tumor relapse and metastasis by regulating cancer-associated fibroblasts

Li, X., Yong, T., Wei, Z., Bie, N., Zhang, X., Zhan, G., Li, J., Qin, J., Yu, J., Zhang, B., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-30306-7 · Cited by 266 · see citing works

Exploiting nanotechnology to overcome tumor drug resistance: Challenges and opportunities

Kirtane, A. R., Kalscheuer, S., & Panyam, J. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.09.001 · Cited by 262 · see citing works

Anti-VEGF therapy induces ECM remodeling and mechanical barriers to therapy in colorectal cancer liver metastases

Rahbari, N. N., Kedrin, D., Incio, J., Liu, H., Ho, W. W., Nia, H. T., Edrich, C. M., Jung, K., Daubriac, J., Chen, I., et al. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aaf5219 · Cited by 258 · see citing works

Cancer-Associated Fibroblasts: Tumorigenicity and Targeting for Cancer Therapy

Glabman, R. A., Choyke, P. L., & Sato, N. (2022) · Cancers · doi:10.3390/cancers14163906 · Cited by 259 · see citing works

Nanoparticles for modulating tumor microenvironment to improve drug delivery and tumor therapy

Yang, S., & Gao, H. (2017) · Pharmacological Research · doi:10.1016/j.phrs.2017.05.004 · Cited by 256 · see citing works

Trial watch

Vacchelli, E., Eggermont, A., Sautès-Fridman, C., Galon, J., Zitvogel, L., Kroemer, G., & Galluzzi, L. (2013) · Oncoimmunology · doi:10.4161/onci.24612 · Cited by 244 · see citing works

Alignment of Cellulose Nanofibers: Harnessing Nanoscale Properties to Macroscale Benefits

Li, K., Clarkson, C. M., Wang, L., Liu, Y., Lamm, M. E., Pang, Z., Zhou, Y., Qian, J., Tajvidi, M., Gardner, D. J., et al. (2021) · ACS Nano · doi:10.1021/acsnano.0c07613 · Cited by 240 · see citing works

Thrombospondin1 in tissue repair and fibrosis: TGF-β-dependent and independent mechanisms

Sweetwyne, M. T., & Murphy-Ullrich, J. E. (2012) · Matrix Biology · doi:10.1016/j.matbio.2012.01.006 · Cited by 239 · see citing works

Approaches to Improve Macromolecule and Nanoparticle Accumulation in the Tumor Microenvironment by the Enhanced Permeability and Retention Effect

Ejigah, V., Owoseni, O., Backer, P. B., Ogundipe, O. D., Fisusi, F. A., & Adesina, S. K. (2022) · Polymers · doi:10.3390/polym14132601 · Cited by 241 · see citing works

Cancer associated fibroblasts in cancer development and therapy

Jia, H., Chen, X., Zhang, L., & Chen, M. (2025) · Journal of Hematology & Oncology · doi:10.1186/s13045-025-01688-0 · Cited by 252 · see citing works

Nanomedicine strategies to overcome the pathophysiological barriers of pancreatic cancer

Adiseshaiah, P. P., Crist, R. M., Hook, S. S., & McNeil, S. E. (2016) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2016.119 · Cited by 239 · see citing works

Why the stroma matters in breast cancer

Conklin, M. W., & Keely, P. J. (2012) · Cell Adhesion & Migration · doi:10.4161/cam.20567 · Cited by 236 · see citing works

AlgiMatrix™ Based 3D Cell Culture System as an In-Vitro Tumor Model for Anticancer Studies

Godugu, C., Patel, A. R., Desai, U. S., Andey, T. A., Sams, A., & Singh, M. S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0053708 · Cited by 234 · see citing works

Heat-Generating Iron Oxide Nanocubes: Subtle “Destructurators” of the Tumoral Microenvironment

Kolosnjaj‐Tabi, J., Corato, R. D., Lartigue, L., Marangon, I., Guardia, P., Silva, A., Luciani, N., Clémеnt, O., Flaud, P., Singh, J. V., et al. (2014) · ACS Nano · doi:10.1021/nn405356r · Cited by 232 · see citing works

Hyperthermia and smart drug delivery systems for solid tumor therapy

Seynhaeve, A. L. B., Amin, M., Haemmerich, D., van Rhoon, G. C., & ten Hagen, T. L. M. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.02.004 · Cited by 235 · see citing works

Magnetic targeting of nanoparticles across the intact blood–brain barrier

Kong, S. D., Lee, J., Ramachandran, S., Eliceiri, B. P., Shubayev, V. I., Lal, R., & Jin, S. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.09.021 · Cited by 226 · see citing works

Enhanced Drug Delivery by Nanoscale Integration of a Nitric Oxide Donor To Induce Tumor Collagen Depletion

Dong, X., Liu, H., Feng, H., Yang, S., Liu, X., Lai, X. P., Lu, Q., Lovell, J. F., Chen, H., & Fang, C. (2019) · Nano Letters · doi:10.1021/acs.nanolett.8b04236 · Cited by 224 · see citing works

Cancer stem cell secretome in the tumor microenvironment: a key point for an effective personalized cancer treatment

López de Andrés, J., Griñán-Lisón, C., Jiménez, G., & Marchal, J. A. (2020) · Journal of Hematology & Oncology · doi:10.1186/s13045-020-00966-3 · Cited by 207 · see citing works

Effective Photothermal Chemotherapy Using Doxorubicin-Loaded Gold Nanospheres That Target EphB4 Receptors in Tumors

You, J., Zhang, R., Xiong, C., Zhong, M., Melancon, M. P., Gupta, S. K., Nick, A. M., Sood, A. K., & Li, C. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-1003 · Cited by 215 · see citing works

Reprogramming the microenvironment with tumor-selective angiotensin blockers enhances cancer immunotherapy

Chauhan, V. P., Chen, I. X., Tong, R., Ng, M. R., Martin, J. D., Naxerova, K., Wu, M. W., Huang, P., Boucher, Y., Kohane, D. S., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1819889116 · Cited by 207 · see citing works

Role of TGFβ in regulation of the tumor microenvironment and drug delivery (Review)

Papageorgis, P., & Stylianopoulos, T. (2015) · International Journal of Oncology · doi:10.3892/ijo.2015.2816 · Cited by 205 · see citing works

Breast Fibroblasts Modulate Early Dissemination, Tumorigenesis, and Metastasis through Alteration of Extracellular Matrix Characteristics

Dumont, N., Liu, B., DeFilippis, R. A., Chang, H., Rabban, J. T., Karnezis, A. N., Tjoe, J. A., Marx, J., Parvin, B., & Tlsty, T. D. (2013) · Neoplasia · doi:10.1593/neo.121950 · Cited by 192 · see citing works

Enhancing tumor penetration of nanomedicines

Sun, Q., Ojha, T., Kiessling, F., Lammers, T., & Shi, Y. (2017) · Biomacromolecules · doi:10.1021/acs.biomac.7b00068 · Cited by 198 · see citing works

Cancer-associated fibroblasts: Origin, function, imaging, and therapeutic targeting

Rimal, R., Desai, P. B., Daware, R., Hosseinnejad, A., Prakash, J., Lammers, T., & Singh, S. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114504 · Cited by 201 · see citing works

TGF-β inhibition combined with cytotoxic nanomedicine normalizes triple negative breast cancer microenvironment towards anti-tumor immunity

Panagi, M., Voutouri, C., Mpekris, F., Papageorgis, P., Martin, M. R., Martin, J. D., Demetriou, P., Pierides, C., Polydorou, C., Stylianou, A., et al. (2020) · Theranostics · doi:10.7150/thno.36936 · Cited by 193 · see citing works

Current Approaches for Improving Intratumoral Accumulation and Distribution of Nanomedicines

Durymanov, M. O., Rosenkranz, A. A., & Sobolev, A. S. (2015) · Theranostics · doi:10.7150/thno.11742 · Cited by 190 · see citing works

Walking the line: The fate of nanomaterials at biological barriers

Meng, H., Leong, W., Leong, K. W., Chen, C., & Zhao, Y. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.04.056 · Cited by 186 · see citing works

Nitric Oxide‐Driven Nanomotor for Deep Tissue Penetration and Multidrug Resistance Reversal in Cancer Therapy

Wan, M. M., Chen, H., Wang, Z. D., Liu, Z. Y., Yu, Y. Q., Li, L., Miao, Z., Wang, X. W., Wang, Q., Mao, C., et al. (2020) · Advanced Science · doi:10.1002/advs.202002525 · Cited by 186 · see citing works

Cancer-Associated Fibroblast (CAF) Heterogeneity and Targeting Therapy of CAFs in Pancreatic Cancer

Geng, X., Chen, H., Zhao, L., Hu, J., Yang, W., Li, G., Cheng, C., Zhao, Z., Zhang, T., Li, L., et al. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.655152 · Cited by 188 · see citing works

Pirfenidone normalizes the tumor microenvironment to improve chemotherapy

Polydorou, C., Mpekris, F., Papageorgis, P., Voutouri, C., & Stylianopoulos, T. (2017) · Oncotarget · doi:10.18632/oncotarget.15534 · Cited by 185 · see citing works

Lymphoid Tissue Damage in HIV-1 Infection Depletes Naïve T Cells and Limits T Cell Reconstitution after Antiretroviral Therapy

Zeng, M., Southern, P. J., Reilly, C., Beilman, G. J., Chipman, J. G., Schacker, T. W., & Haase, A. T. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1002437 · Cited by 182 · see citing works

Nanoformulations for combination or cascade anticancer therapy

Miao, L., Guo, S., Lin, C. M., Liu, Q., & Huang, L. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.06.003 · Cited by 178 · see citing works

Losartan loaded liposomes improve the antitumor efficacy of liposomal paclitaxel modified with pH sensitive peptides by inhibition of collagen in breast cancer

Xia, T., He, Q., Shi, K., Wang, Y., Yu, Q., Zhang, L., Zhang, Q., Gao, H., Ma, L., & Liu, J. (2016) · Pharmaceutical Development and Technology · doi:10.1080/10837450.2016.1265553 · Cited by 47 · see citing works

A dual strategy to improve the penetration and treatment of breast cancer by combining shrinking nanoparticles with collagen depletion by losartan

Cun, X., Ruan, S., Chen, J., Zhang, L., Li, J., He, Q., & Gao, H. (2015) · Acta Biomaterialia · doi:10.1016/j.actbio.2015.12.002 · Cited by 115 · see citing works

Depletion of collagen by losartan to improve tumor accumulation and therapeutic efficacy of photodynamic nanoplatforms

Tang, Y., Liu, Y., Wang, S., Tian, Y., Li, Y., Teng, Z., & Lu, G. (2019) · Drug Delivery and Translational Research · doi:10.1007/s13346-018-00610-1 · Cited by 31 · see citing works

Intratumoral injection of gels containing losartan microspheres and (PLG-g-mPEG)-cisplatin nanoparticles improves drug penetration, retention and anti-tumor activity

Yu, M., Zhang, C., Tang, Z., Tang, X., & Xu, H. (2018) · Cancer Letters · doi:10.1016/j.canlet.2018.11.011 · Cited by 51 · see citing works

High Tumor Penetration of Paclitaxel Loaded pH Sensitive Cleavable Liposomes by Depletion of Tumor Collagen I in Breast Cancer

Zhang, L., Wang, Y., Yang, Y., Liu, Y., Ruan, S., Zhang, Q., Tai, X., Chen, J., Xia, T., Qiu, Y., et al. (2015) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.5b01473 · Cited by 107 · see citing works